Forte Biosciences Inc. (FBRX)
NASDAQ: FBRX
· Real-Time Price · USD
11.85
1.03 (9.52%)
At close: Aug 15, 2025, 3:59 PM
11.61
-2.03%
After-hours: Aug 15, 2025, 04:53 PM EDT
Forte Biosciences Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -15.66M | -7.16M | -8.39M | -12.51M | -7.42M | -5.87M | -9.96M | -8.9M | -6.75M | -4.88M | -3.4M | -3.04M | -2.57M | -3.34M | -7.75M | -5.81M | -4.8M |
Depreciation & Amortization | 13K | 10K | 10K | 10K | 9K | 6K | 3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 9K | 13K | 14K |
Stock-Based Compensation | 1.62M | 697K | 791K | 802K | 805K | 780K | 772K | 855K | 877K | 860K | 906K | 1.19M | 1.05M | 1.24M | 1.47M | 1.01M | 495K |
Other Working Capital | n/a | -2.69M | -435K | 2.18M | -316K | -25K | -2.04M | 923K | -189K | 1.11M | 88K | 371K | -93K | -95K | -264K | 1.07M | 299K |
Other Non-Cash Items | n/a | -156K | 9K | 3.58K | -6K | 4.67M | -115K | -21K | 688K | 842K | 440K | 1.1M | 1.43M | 2.62M | 61K | 1.25M | 557K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | -4.66M | -3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | n/a | -3.4M | -551K | 5.77M | -55K | -3.89M | 240K | 2.59M | 672K | 1.12M | 554K | 464K | -463K | -1.48M | 1.08M | 853K | 265K |
Operating Cash Flow | -10.36M | -10.01M | -8.13M | -5.94M | -6.67M | -8.97M | -9.06M | -5.47M | -5.2M | -2.89M | -1.94M | -1.38M | -1.98M | -3.58M | -5.13M | -3.94M | -4.03M |
Capital Expenditures | -61K | -31K | n/a | n/a | -6K | -17K | -71K | n/a | n/a | n/a | n/a | n/a | n/a | 61K | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | -35.96M | n/a | n/a | n/a | n/a | n/a | -9.96M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | 36.35M | n/a | n/a | n/a | n/a | 1K | 10.1M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | 10.1K | -9.96K | n/a | n/a | n/a | n/a | n/a | -61K | n/a | n/a | n/a |
Investing Cash Flow | 36.29M | -35.99M | n/a | n/a | -6K | -16K | 10.03M | -9.96M | n/a | n/a | n/a | n/a | n/a | 61K | n/a | n/a | n/a |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | 26K | -10K | -16K | -75 | -24 | -24 | n/a | -55K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | -2.33M | -1.12M | -7K | -10K | -8K | -11K | 24.78M | n/a | 6K | n/a | 7.44M | -110K | -34K | -39K | -3K | -29K | 27K |
Financial Cash Flow | -2.32M | 51.88M | -2K | -10K | -8K | -75K | 24.78M | -24K | 6K | -55K | 7.44M | -110K | -34K | -39K | -3K | -29K | 27K |
Net Cash Flow | 23.61M | 5.88M | -8.13M | -5.95M | -6.68M | -9.18M | 25.75M | -15.46M | -5.2M | -2.95M | 5.5M | -1.49M | -2.01M | -3.62M | -5.13M | -3.97M | -4M |
Free Cash Flow | -10.42M | -10.04M | -8.13M | -5.94M | -6.67M | -8.99M | -9.13M | -5.47M | -5.2M | -2.89M | -1.94M | -1.38M | -1.98M | -3.52M | -5.13M | -3.94M | -4.03M |